MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma.

BACKGROUND microRNAs (miRNAs) play a significant role in cancer development and progression by regulating the expression of oncogenes or tumor suppressor genes. Previous study using microarrays demonstrated that miR-142-3p was downregulated in patients with Non-small-cell lung carcinoma (NSCLC). However, the functional role of miR-142-3p in NSCLC is still unclear. MATERIAL AND METHOD Real-time quantitative PCR was applied to evaluate the expression level of miRNA-142-3p in NSCLC and normal samples. The cell proliferation of NSCLC cells was analyzed by MTT and colony formation assay after miR-142-3p transfection. Luciferase activities assay, cotransfection and Western blot were used to reveal that the predicted target genes of miR-125b were direct and specific. RESULTS In this study, we demonstrate miR-142-3p was downregulated in NSCLC tissues and cell lines. We demonstrated that the overexpression of miR-142-3p inhibits NSCLC cell proliferation and induced cell apoptosis. Furthermore, we demonstrate HMGB1 was a directly target of miR-142-3p in NSCLC cells, and confirmed the target specificity between miR-142-3p and the HMGB1 3'-untranslated region by luciferase reporter assay. CONCLUSIONS These results suggest that miR-142-3p may be a tumor suppressor through the downregulation of HMGB1 in NSCLC. miR-142-3p may be a tumor suppressor and a potential therapeutic agent for patients with NSCLC.

[1]  G. S. Johnson,et al.  Endogenous ADP ribosylation of high mobility group proteins 1 and 2 and histone H1 following DNA damage in intact cells. , 1985, Archives of biochemistry and biophysics.

[2]  Anne-Marie Cleton-Jansen,et al.  Modulation of the Osteosarcoma Expression Phenotype by MicroRNAs , 2012, PloS one.

[3]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[4]  A. Bosserhoff,et al.  Transcription factors involved in development and progression of malignant melanoma. , 2004, Histology and histopathology.

[5]  Pei-ying Zhang,et al.  MicroRNA-10b targets E-cadherin and modulates breast cancer metastasis , 2012, Medical science monitor : international medical journal of experimental and clinical research.

[6]  V. Ambros.  MicroRNA Pathways in Flies and Worms Growth, Death, Fat, Stress, and Timing , 2003, Cell.

[7]  Hermann Brenner,et al.  Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. , 2007, The Lancet. Oncology.

[8]  Zhongmin Liu,et al.  HMGB1 was a pivotal synergistic effecor for CpG oligonucleotide to enhance the progression of human lung cancer cells , 2012, Cancer biology & therapy.

[9]  M. Rocchi,et al.  The active gene that encodes human high mobility group 1 protein (HMG1) contains introns and maps to chromosome 13. , 1996, Genomics.

[10]  L. Ulloa,et al.  High-mobility group box 1 (HMGB1) protein: friend and foe. , 2006, Cytokine & growth factor reviews.

[11]  Yunhui Liu,et al.  MiR-210 Up-Regulation Inhibits Proliferation and Induces Apoptosis in Glioma Cells by Targeting SIN3A , 2014, Medical science monitor : international medical journal of experimental and clinical research.

[12]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[13]  Stefan Joos,et al.  HMGB1 inhibits cell death in yeast and mammalian cells and is abundantly expressed in human breast carcinoma , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  Po-Len Liu,et al.  High-mobility group box 1-mediated matrix metalloproteinase-9 expression in non-small cell lung cancer contributes to tumor cell invasiveness. , 2010, American journal of respiratory cell and molecular biology.

[15]  M. Lotze,et al.  High‐mobility group box 1 activates caspase‐1 and promotes hepatocellular carcinoma invasiveness and metastases , 2012, Hepatology.

[16]  C. Shang,et al.  MicroRNA-125b down-regulation mediates endometrial cancer invasion by targeting ERBB2 , 2012, Medical science monitor : international medical journal of experimental and clinical research.

[17]  L. Borrmann,et al.  Variation of HMGB1 expression in breast cancer. , 2001, Anticancer research.

[18]  S. Joos,et al.  Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas , 2005, Gut.

[19]  Guo-Hui Fu,et al.  MiR-142-3p functions as a tumor suppressor by targeting CD133, ABCG2, and Lgr5 in colon cancer cells , 2013, Journal of Molecular Medicine.

[20]  G. S. Johnson,et al.  ADP-ribosylation of nonhistone high mobility group proteins in intact cells. , 1983, The Journal of biological chemistry.

[21]  C. Croce,et al.  MicroRNAs and chromosomal abnormalities in cancer cells , 2006, Oncogene.

[22]  Min Liu,et al.  MicroRNA‐142‐3p, a new regulator of RAC1, suppresses the migration and invasion of hepatocellular carcinoma cells , 2011, FEBS letters.

[23]  Yi-ming Li,et al.  Downregulation of ABCG2 expression in glioblastoma cancer stem cells with miRNA-328 may decrease their chemoresistance. , 2010, Medical science monitor : international medical journal of experimental and clinical research.

[24]  M. Kaksonen,et al.  Heparin-binding proteins HB-GAM (pleiotrophin) and amphoterin in the regulation of cell motility. , 2000, Matrix biology : journal of the International Society for Matrix Biology.

[25]  Rolf-Edgar Silber,et al.  Journal section: , 2004 .

[26]  Subbaya Subramanian,et al.  Triptolide Induces the Expression of miR-142-3p: A Negative Regulator of Heat Shock Protein 70 and Pancreatic Cancer Cell Proliferation , 2013, Molecular Cancer Therapeutics.